Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Pulak Kar, Professor Anant Parekh and colleagues are a step closer to understanding how specificity is achieved in the immune system.

Of the thousands of chemical signals that land on a cell’s surface each day, only a handful of intracellular messengers are used to produce a physiological effect. Amongst the small number of signals employed, intracellular calcium is the most widespread, activating a range of important responses including neurotransmission, beating of the heart, energy production and cell growth. However, with the same message capable of activating so many different processes comes the question of specificity: how does a cell know what to do when the intracellular calcium levels rise? Dr Pulak Kar, Professor Anant Parekh and colleagues are a step closer to understanding how specificity is achieved in the immune system. The team’s research in Current Biology (24, 1361-1368) show that a protein signalling complex forms at the cell periphery close to a calcium channel called the CRAC channel that lets calcium ions enter the cell. As the calcium enters, its target is immediately and selectively activated. This mechanism explains how different ways of increasing calcium activates different cellular responses. The results also reveal that targeting the CRAC channel therapeutically should be an effective approach to control the severity of an immune response.

Similar stories

New blood test from DPAG cardiac researchers could save lives of heart attack victims

Researchers from the Herring group have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.